Annette Stokes
Family Medicine · Menomonee Falls, WINPI 1801956214
Payments from drug & device makers
Across 188 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$842
- Gilead$733
- AstraZeneca$575
- Lilly USA, LLC$299
- Pfizer$276
- Novo Nordisk$136
- plus $897 from 17 others
What the payments were for
- Food & beverage$3,757100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $842 |
| Gilead | 23 | $733 |
| AstraZeneca | 28 | $575 |
| Lilly USA, LLC | 18 | $299 |
| Pfizer | 13 | $276 |
| Novo Nordisk | 7 | $136 |
| Nestle Healthcare Nutrition Inc. | 5 | $110 |
| Aimmune Therapeutics, Inc. | 5 | $102 |
| Bayer | 6 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $93 |
| Boehringer Ingelheim | 3 | $79 |
| Johnson & Johnson | 3 | $60 |
| Novartis | 3 | $59 |
| GSK | 3 | $58 |
| Exact Sciences | 2 | $42 |
| Merck | 2 | $36 |
| Ardelyx, Inc. | 2 | $34 |
| Ironwood Pharmaceuticals, Inc | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,757 in reported general payments places this provider in the 90th percentile of 1,482 family medicine providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 58 | $37,235 |
| OzempicSemaglutide | 21 | $20,032 |
| FarxigaDapagliflozin Propanediol | 24 | $15,807 |
| LinzessLinaclotide | 21 | $15,226 |
| JardianceEmpagliflozin | 14 | $12,474 |
| EliquisApixaban | 21 | $11,987 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $6,924 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 16 | $3,868 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,824 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 117 | $2,532 |
| Gabapentin | 45 | $811 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 11 | $765 |
| Omeprazole | 71 | $722 |
| Amlodipine Besylate | 89 | $585 |
| Atorvastatin Calcium | 69 | $553 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $58 | $44,16071 claims |
| Novo NordiskOzempic | $136 | $20,03221 claims |
| AstraZenecaFarxiga, Symbicort | $575 | $18,63236 claims |
| AbbVieLinzess | $842 | $15,22621 claims |
| Boehringer IngelheimJardiance | $79 | $12,47414 claims |
| PfizerEliquis | $276 | $11,98721 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,482 family medicine providers in Wisconsin.
Other family medicine in Menomonee Falls
- Taha El-ShahatMadison$15.6M
- Jonathan MeimanMadison$4.3M
- John AgaibyKenosha$4M
- John LaabsShawano$3.6M
- Jennifer ParsleyElk Mound$1.4M
- William PalinMilwaukee$693K
- Jonathan TemteMadison$542K
- Ryan AndrewsStevens Point$429K
- Tara DallDelafield$230K
- Mark JensonGreen Bay$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.